Leveraging Transdermal Alcohol Monitoring to Reduce Drinking Among DWI Defendants

NCT ID: NCT03638596

Last Updated: 2024-05-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

158 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-05-01

Study Completion Date

2021-03-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The current study will evaluate the efficacy of contingency management (i.e., reinforcement for avoiding heavy drinking) among adults arrested for drunk driving and who are at risk for ongoing heavy drinking.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Individuals who have a drunk driving arrest and are at risk for ongoing heavy drinking will be recruited to test the efficacy of contingency management for reducing alcohol use and identifying mechanisms of change. We will recruit those arrested for drunk driving offenses, ≥ 21 years of age, who at risk for ongoing heavy alcohol use and randomize them to one of two groups: control or a contingency management. Participants experience 8 weekly assessments of current alcohol use and other variables associated with changes in alcohol use. Post-intervention, participants will return to the laboratory once per month at 3, 6, 9, and 12 months post-study entry for follow-up procedures to determine the mechanisms of drinking behavior change.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Drunk Driving

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

random assignment to treatment and control arms
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Contingency Management

Incentive delivery contingent upon maintaining transdermal alcohol concentration below cut-off

Group Type EXPERIMENTAL

Contingency Management

Intervention Type BEHAVIORAL

Incentive provided for changing alcohol drinking patterns based on ankle monitor

Control

Incentive delivery not contingent on transdermal alcohol concentration

Group Type PLACEBO_COMPARATOR

Control

Intervention Type BEHAVIORAL

Incentive provided is not contingent on alcohol drinking patterns based on ankle monitor

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Contingency Management

Incentive provided for changing alcohol drinking patterns based on ankle monitor

Intervention Type BEHAVIORAL

Control

Incentive provided is not contingent on alcohol drinking patterns based on ankle monitor

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* arrested for drunk driving offense

Exclusion Criteria

* significant alcohol withdrawal symptoms
* medical condition that would contraindicate participation (e.g., pregnancy, scheduled surgery)
* inability to comprehend the informed consent process or study instructions
* presence of a DSM-5 psychiatric disorder with symptoms of psychosis and/or delirium
* incarceration
Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

Sponsor Role collaborator

The University of Texas Health Science Center at San Antonio

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nathalie Hill-Kapturczak, PhD

Role: PRINCIPAL_INVESTIGATOR

The University of Texas Health Science Center San Antonio

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Texas Health Science Center San Antonio

San Antonio, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

5R01AA014988

Identifier Type: NIH

Identifier Source: secondary_id

View Link

HSC20160425H

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Multi-Component Breath Alcohol Intervention
NCT06124898 ACTIVE_NOT_RECRUITING NA
Brief Intervention for Heavy Drinkers
NCT00728767 COMPLETED PHASE3
Smartphone Technology: Young Adult Drinking
NCT02963818 COMPLETED PHASE1/PHASE2
Behavior and Driving Safety Study
NCT00575679 COMPLETED NA